APOP - セレクト・バイオテクノロジ― (Cellect Biotechnology Ltd.) セレクト・バイオテクノロジ―

 APOPのチャート


 APOPの企業情報

symbol APOP
会社名 Cellect Biotechnology Ltd (セレクト・バイオテクノロジ―)
分野(sector)   
産業(industry)   
業種    医療関連(Health Care)
概要 事業概要 --   セレクト・バイオテクノロジ―はイスラエルのバイオ医薬品企業。主に、免疫細胞治療、幹細胞治療、再生医療の開発に従事する。同社のプラットフォ―ムは幹細胞の特性に基づき、アポト―シス(細胞死)誘導エ―ジェントを開発する。動物実験では成果があり、今後は臨床試験やパイプラインの開発に取り組む。本社はクファ―ルサバ。   Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. Cellect Biotechnology was founded by Kasbian Nuriel Chirich, Shai Yarkoni and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.
本社所在地 23 Ha'Taas St. Kfar Saba ISR
代表者氏名
代表者役職名
電話番号
設立年月日
市場名 NASDAQ Small Cap
ipoyear 2016年
従業員数
url www.cellectbio.com
nasdaq_url https://www.nasdaq.com/symbol/apop
adr_tso 6468992
EBITDA EBITDA ー
終値(lastsale) 4.8073
時価総額(marketcap) 31098385.2416
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 APOPのテクニカル分析


 APOPのニュース

   The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering  2019/08/08 11:11:00 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 7) Akero Therapeutics Inc (NASDAQ: AKRO ) Allakos Inc (NASDAQ: ALLK ) Cytokinetics, Inc. (NASDAQ: CYTK ) Guardant Health Inc (NASDAQ: GH ) (reacted to strong second-quarter results) Morphic Holding Inc (NASDAQ: MORF ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 7) ABIOMED, Inc. (NASDAQ: ABMD ) Assertio Therapeutics Inc (NASDAQ: ASRT ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BioCardia Inc (NASDAQ: BCDA ) BIOLINERX LTD/S ADR (NASDAQ: BLRX ) Biopharmx Corp NYSE: (BPMX) CAN-FITE BIOPHA/S ADR (NYSE: CANF ) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) Cellular Biomedicine Group Inc (NASDAQ: CBMG )(reacted to second-quarter results) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX )(reported second-quarter results) Guardion Health Sciences Inc (NASDAQ: GHSI )(announced common stock offering of 9.
   The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout  2019/08/07 11:34:05 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 6) Allakos Inc (NASDAQ: ALLK )(announced common stock offering) Cytokinetics, Inc. (NASDAQ: CYTK ) Insulet Corporation (NASDAQ: PODD )( reacted to forecast-beating second-quarter results) Fulgent Genetics Inc (NASDAQ: FLGT )(moved in reaction to second-quarter earnings) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 6) Abeona Therapeutics Inc (NASDAQ: ABEO ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM )(reacted to second-quarter results) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BIOLINERX LTD/S ADR (NASDAQ: BLRX )(reacted to second-quarter results) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) ChemoCentryx Inc (NASDAQ: CCXI )(reported below-consensus second-quarter revenues) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Endo International PLC (NASDAQ: ENDP )(reacted to second-quarter results) Equillium Inc (NASDAQ: EQ ) Evogene Ltd (NASDAQ: EVGN ) Hepion Pharmaceuticals Inc (NASDAQ: HEPA ) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) MEI Pharma Inc (NASDAQ: MEIP ) Merit Medical Systems, Inc.
   The Daily Biotech Pulse: Takeda Pulls Plug On Amyloidosis Drug Trial, Chiasma Preps For Drug Launch With New CEO Appointment, Orchard Prices Offering  2019/06/06 11:37:34 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 5) Array Biopharma Inc (NASDAQ: ARRY ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) BIOFRONTERA AG/ADR (NASDAQ: BFRA ) EXACT Sciences Corporation (NASDAQ: EXAS ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Misonix, Inc. (NASDAQ: MSON ) Repligen Corporation (NASDAQ: RGEN ) Uniqure NV (NASDAQ: QURE ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on June 5) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Arbutus Biopharma Corp (NASDAQ: ABUS ) Caladrius Biosciences Inc (NASDAQ: CLBS ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) ChemoCentryx Inc (NASDAQ: CCXI )(moved in sympathy with its rival, which has a competing drug) Collegium Pharmaceutical Inc (NASDAQ: COLL ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Cyclerion Therapeutics Inc (NASDAQ: CYCN ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Harvard Bioscience, Inc.
   The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering  2019/05/17 12:03:47 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on May 16) Adverum Biotechnologies Inc (NASDAQ: ADVM )(announced lifting of FDA's partial clinical hold on the second cohort of Phase 1 study of its wet age-related macular degeneration drug) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Fate Therapeutics Inc (NASDAQ: FATE ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Masimo Corporation (NASDAQ: MASI )(received FDA nod for Radius PPG, a tetherless sensor solution) MediciNova, Inc. (NASDAQ: MNOV ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) TransMedics Group Inc (NASDAQ: TMDX ) Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 16) Auris Medical Holding Ltd (NASDAQ: EARS ) CELLECT BIOTECH/S ADR (NASDAQ: APOP )(announced exploration of strategic alternatives) Enochian Biosciences Inc (NASDAQ: ENOB ) NGM Biopharmaceuticals Inc (NASDAQ: NGM ) Nuvectra Corp (NASDAQ: NVTR )(announced departure of COO and CFO) Precision Therapeutics Inc (NASDAQ: AIPT )(reacted to its first-quarter results) Sellas Life Sciences Group Inc (NASDAQ: SLS ) (reacted to its first-quarter results) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Tonix …
   The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stock To Debut  2019/05/09 11:56:36 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 8) Alcon AG (NYSE: ALC ) BioSig Technologies Inc (NASDAQ: BSGM ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 8) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Aquestive Therapeutics Inc (NASDAQ: AQST )(reacted to first-quarter results) Arbutus Biopharma Corp (NASDAQ: ABUS ) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) Flexion Therapeutics Inc (NASDAQ: FLXN ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Opko Health Inc. (NASDAQ: OPK )(reacted to Q1 results) Osmotica Pharmaceuticals PLC (NASDAQ: OSMT ) Retrophin Inc (NASDAQ: RTRX ) Revance Therapeutics Inc (NASDAQ: RVNC ) Sensus Healthcare Inc (NASDAQ: SRTS ) Stock In Focus Novartis to Buy Dry Eye Disease Drug From Takeda For $3.4B Novartis AG (NYSE: NVS ) announced an agreement with Takeda Pharmaceutical Co Ltd (NYSE: TAK ) to acquire the assets associated with Xildra, chemically lifitefgrast ophthalmic solution, 5 percent worldwide for a $3.4 billion payment upfront and potential milestone payments up to $1.9 billion.
   Cellect Biotechnology reports Q1 results  2019-05-21
Cellect Biotechnology (NASDAQ: APOP ): Q1 GAAP EPADS of -$0.16. Cash and cash equivalents of $9.59M Press Release More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, ,
   Cellect Biotechnology Reports First Quarter 2019 Financial and Operating Results  2019-05-21 PR Newswire
TEL AVIV, Israel , May 21, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported financial and operating results for the first quarter ended March 31, 2019 and provided a …
   Cellect Bio up 17% premarket on positive ApoGraft data  2019-03-27
Thinly traded nano cap Cellect Biotechnology (NASDAQ: APOP ) is up 17% premarket on modestly higher volume in reaction to positive preliminary results from a Phase 1/2 clinical trial evaluating its ApoGraft stem cell selection technology in patients undergoing stem cell transpl…
   Cellect Announces Positive Phase I/II Mid-Study Results of Its ApoGraft(TM) Technology  2019-03-27 PR Newswire
TEL AVIV, Israel , March 27, 2019 /PRNewswire/ --Further validating its ApoGrafttechnology, Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced positive mid-study data from the Company's Phase I/II study of its A…

 関連キーワード  (― 米国株 セレクト・バイオテクノロジ― APOP Cellect Biotechnology Ltd.)

 twitter  (公式ツイッターやCEOツイッターなど)